Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?

about

Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?

Item

http://www.wikidata.org/entity/Q53702234

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Bax, Bcl-2, and Bax/Bcl-2 as p ...... dy for Bcl-2-directed therapy?

@en

Bax, Bcl-2, and Bax/Bcl-2 as p ...... dy for Bcl-2-directed therapy?

@nl

type

Item

label

Bax, Bcl-2, and Bax/Bcl-2 as p ...... dy for Bcl-2-directed therapy?

@en

Bax, Bcl-2, and Bax/Bcl-2 as p ...... dy for Bcl-2-directed therapy?

@nl

prefLabel

Bax, Bcl-2, and Bax/Bcl-2 as p ...... dy for Bcl-2-directed therapy?

@en

Bax, Bcl-2, and Bax/Bcl-2 as p ...... dy for Bcl-2-directed therapy?

@nl

P1476

Bax, Bcl-2, and Bax/Bcl-2 as p ...... dy for Bcl-2-directed therapy?

@en

P2093

Bibi Kulsoom

http://www.w3.org/2001/XMLSchema#string

Nasir Ali Afsar

http://www.w3.org/2001/XMLSchema#string

Nikhat Ahmed

http://www.w3.org/2001/XMLSchema#string

Syed Nazrul Hasnain

http://www.w3.org/2001/XMLSchema#string

Zahida Memon

http://www.w3.org/2001/XMLSchema#string

P2860

MCL-1ES, a novel variant of MCL-1, associates with MCL-1L and induces mitochondrial cell death

Global cancer statistics, 2012

Analyzing real-time PCR data by the comparative C(T) method

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

The BCL-2 protein family: opposing activities that mediate cell death

Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo.

Both leukaemic and normal peripheral B lymphoid cells are highly sensitive to the selective pharmacological inhibition of prosurvival Bcl-2 with ABT-199.

Prognosis of acute myeloid leukemia in the general population: data from southern Switzerland.

A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy.

The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies.

P304

403-416

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CMAR.S154608

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tahir Shamsi

P577

2018-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29535553

http://www.w3.org/2001/XMLSchema#string

P932

5841349

http://www.w3.org/2001/XMLSchema#string